These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 12820390

  • 1. Immunohistochemical evaluation of PCNA, p53, HSP60, HSP10 and MUC-2 presence and expression in prostate carcinogenesis.
    Cappello F, Rappa F, David S, Anzalone R, Zummo G.
    Anticancer Res; 2003; 23(2B):1325-31. PubMed ID: 12820390
    [Abstract] [Full Text] [Related]

  • 2. Immunohistochemical expression of retinoblastoma and p53 tumor suppressor genes in prostatic intraepithelial neoplasia: comparison with prostatic adenocarcinoma and benign prostate.
    Tamboli P, Amin MB, Xu HJ, Linden MD.
    Mod Pathol; 1998 Mar; 11(3):247-52. PubMed ID: 9521470
    [Abstract] [Full Text] [Related]

  • 3. Expression of ezrin in prostatic intraepithelial neoplasia.
    Pang ST, Fang X, Valdman A, Norstedt G, Pousette A, Egevad L, Ekman P.
    Urology; 2004 Mar; 63(3):609-12. PubMed ID: 15028477
    [Abstract] [Full Text] [Related]

  • 4. Upregulation of erythropoietin receptor in human prostate carcinoma and high-grade prostatic intraepithelial neoplasia.
    Zhou T, Xu C, He M, Sun Y.
    Prostate Cancer Prostatic Dis; 2008 Mar; 11(2):143-7. PubMed ID: 17637760
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The value of immunohistochemical research on PCNA, p53 and heat shock proteins in prostate cancer management: a review.
    Cappello F, Ribbene A, Campanella C, Czarnecka AM, Anzalone R, Bucchieri F, Palma A, Zummo G.
    Eur J Histochem; 2006 Mar; 50(1):25-34. PubMed ID: 16584982
    [Abstract] [Full Text] [Related]

  • 7. Immunohistochemical expression of Hsp60 correlates with tumor progression and hormone resistance in prostate cancer.
    Castilla C, Congregado B, Conde JM, Medina R, Torrubia FJ, Japón MA, Sáez C.
    Urology; 2010 Oct; 76(4):1017.e1-6. PubMed ID: 20708221
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Ki-67 antigen and P53 protein expression in benign and malignant prostatic lesions. Immunohistochemical quantitative study.
    Sasor A, Wagrowska-Danilewicz M, Danilewicz M.
    Pol J Pathol; 2000 Oct; 51(1):31-6. PubMed ID: 10833901
    [Abstract] [Full Text] [Related]

  • 12. p53 Alteration and chromosomal instability in prostatic high-grade intraepithelial neoplasia and concurrent carcinoma: analysis by immunohistochemistry, interphase in situ hybridization, and sequencing of laser-captured microdissected specimens.
    Al-Maghrabi J, Vorobyova L, Chapman W, Jewett M, Zielenska M, Squire JA.
    Mod Pathol; 2001 Dec; 14(12):1252-62. PubMed ID: 11743048
    [Abstract] [Full Text] [Related]

  • 13. Aberrant CpG island hypermethylation of multiple genes in prostate cancer and prostatic intraepithelial neoplasia.
    Kang GH, Lee S, Lee HJ, Hwang KS.
    J Pathol; 2004 Feb; 202(2):233-40. PubMed ID: 14743506
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The expression of thrombospondin-1 in benign prostatic hyperplasia and prostatic intraepithelial neoplasia is decreased in prostate cancer.
    Vallbo C, Wang W, Damber JE.
    BJU Int; 2004 Jun; 93(9):1339-43. PubMed ID: 15180634
    [Abstract] [Full Text] [Related]

  • 16. Signal transducer and activator of transcription-6 (STAT6) is a constitutively expressed survival factor in human prostate cancer.
    Das S, Roth CP, Wasson LM, Vishwanatha JK.
    Prostate; 2007 Oct 01; 67(14):1550-64. PubMed ID: 17705178
    [Abstract] [Full Text] [Related]

  • 17. Immunohistochemical characterization of canine prostatic intraepithelial neoplasia.
    Matsuzaki P, Cogliati B, Sanches DS, Chaible LM, Kimura KC, Silva TC, Real-Lima MA, Hernandez-Blazquez FJ, Laufer-Amorim R, Dagli ML.
    J Comp Pathol; 2010 Jan 01; 142(1):84-8. PubMed ID: 19643431
    [Abstract] [Full Text] [Related]

  • 18. Expression of prostate stem cell antigen in high-grade prostatic intraepithelial neoplasia and prostate cancer.
    Barbisan F, Mazzucchelli R, Santinelli A, Scarpelli M, Lopez-Beltran A, Cheng L, Montironi R.
    Histopathology; 2010 Oct 01; 57(4):572-9. PubMed ID: 20955382
    [Abstract] [Full Text] [Related]

  • 19. Evidence of multifocality of telomere erosion in high-grade prostatic intraepithelial neoplasia (HPIN) and concurrent carcinoma.
    Vukovic B, Park PC, Al-Maghrabi J, Beheshti B, Sweet J, Evans A, Trachtenberg J, Squire J.
    Oncogene; 2003 Apr 03; 22(13):1978-87. PubMed ID: 12673203
    [Abstract] [Full Text] [Related]

  • 20. Amphiregulin expression in prostatic intraepithelial neoplasia and adenocarcinoma: a study of 93 cases.
    Bostwick DG, Qian J, Maihle NJ.
    Prostate; 2004 Feb 01; 58(2):164-8. PubMed ID: 14716741
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.